Getagraph.com logo
S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

Sanntidsoppdatering for Vicore Pharma Holding AB [VICO.ST]

Børs: STO Sektor: Healthcare Industri: Biotechnology
Sist oppdatert3 mai 2024 @ 17:29
25% discount on Stockinvest.us - Use code: Podcast

1.91% SEK 19.24

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 17:29):

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF...

Stats
Dagens volum 379 319
Gjennomsnittsvolum 214 211
Markedsverdi 2.15B
EPS SEK0 ( 2024-05-03 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -5.98
ATR14 SEK0.0400 (0.21%)

Volum Korrelasjon

Lang: -0.09 (neutral)
Kort: 0.56 (weak)
Signal:(51.568) Neutral

Vicore Pharma Holding AB Korrelasjon

10 Mest positive korrelasjoner
10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Vicore Pharma Holding AB Korrelasjon - Valuta/Råvare

The country flag -0.03
( neutral )
The country flag 0.26
( neutral )
The country flag -0.84
( strong negative )
The country flag -0.82
( strong negative )
The country flag 0.74
( moderate )

Vicore Pharma Holding AB Økonomi

Annual 2023
Omsetning: SEK0
Bruttogevinst: SEK-3.42M (0.00 %)
EPS: SEK-3.22
FY 2023
Omsetning: SEK0
Bruttogevinst: SEK-3.42M (0.00 %)
EPS: SEK-3.22
FY 2022
Omsetning: SEK0
Bruttogevinst: SEK-3.61M (0.00 %)
EPS: SEK-3.99
FY 2021
Omsetning: SEK0.00
Bruttogevinst: SEK0.00 (0.00 %)
EPS: SEK-4.25

Financial Reports:

No articles found.

Vicore Pharma Holding AB

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.

Om Live Signaler

Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.

Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.